Globus Medical, Inc.

NYSE:GMED Stock Report

Market Cap: US$8.3b

Globus Medical Past Earnings Performance

Past criteria checks 3/6

Globus Medical's earnings have been declining at an average annual rate of -1.5%, while the Medical Equipment industry saw earnings growing at 14.9% annually. Revenues have been growing at an average rate of 27.3% per year. Globus Medical's return on equity is 4.5%, and it has net margins of 7.4%.

Key information

-1.48%

Earnings growth rate

-6.34%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate27.33%
Return on equity4.54%
Net Margin7.39%
Last Earnings Update31 Mar 2025

Recent past performance updates

There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings

Mar 05
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings

Recent updates

Globus Medical, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 11
Globus Medical, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

At US$71.91, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List?

May 05
At US$71.91, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List?

Globus Medical: Digesting Another Acquisition

Apr 23

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 38% Undervalued

Apr 20
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 38% Undervalued

There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings

Mar 05
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings

Globus Medical: Some Caution After Its Deal For Nevro

Feb 16

Subdued Growth No Barrier To Globus Medical, Inc.'s (NYSE:GMED) Price

Jan 31
Subdued Growth No Barrier To Globus Medical, Inc.'s (NYSE:GMED) Price

Globus Medical Stock: Re-Rated After A Solid Year

Nov 18

Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Nov 04
Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Oct 14
Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Globus Medical: A Post Acquisition Analysis

Aug 26
author-image

Calculated Initiatives And Innovative Technologies Propel Growth In Medical Equipment Sector

Strategic integration and new product launches aim to increase Globus Medical's market share and future revenue through enhanced offerings.

Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

Jun 28
Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Globus Medical: Merger Overhang Lingering

Nov 27

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Globus Medical Q4 2022 Earnings Preview

Feb 20

Revenue & Expenses Breakdown

How Globus Medical makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:GMED Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 252,511186972137
31 Dec 242,519103977162
30 Sep 242,47992972182
30 Jun 242,23741888177
31 Mar 241,89867770160
31 Dec 231,568123643124
30 Sep 231,22615851791
30 Jun 231,09720446781
31 Mar 231,06920145477
31 Dec 221,02319043273
30 Sep 22998155421105
30 Jun 22974155410102
31 Mar 22961142411100
31 Dec 2195814940897
30 Sep 2194218739462
30 Jun 2192818438660
31 Mar 2182612235984
31 Dec 2078910235585
30 Sep 207679535585
30 Jun 207478935485
31 Mar 2079314836361
31 Dec 1978515535560
30 Sep 1977014634658
30 Jun 1974314333359
31 Mar 1972215032257
31 Dec 1871315631255
30 Sep 1869314430053
30 Jun 1867613428949
31 Mar 1865511827646
31 Dec 1763610726744
30 Sep 1761210725642
30 Jun 1759510824741
31 Mar 1758110523541
31 Dec 1656410422241
30 Sep 1655311821441
30 Jun 1655411821240
31 Mar 1654811621238
31 Dec 1553711321036
30 Sep 1551810320535
30 Jun 154999920034
31 Mar 154819619333
31 Dec 144679218931
30 Sep 144548618630
30 Jun 144438318428

Quality Earnings: GMED has a large one-off loss of $199.8M impacting its last 12 months of financial results to 31st March, 2025.

Growing Profit Margin: GMED's current net profit margins (7.4%) are higher than last year (3.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: GMED's earnings have declined by 1.5% per year over the past 5 years.

Accelerating Growth: GMED's earnings growth over the past year (178.5%) exceeds its 5-year average (-1.5% per year).

Earnings vs Industry: GMED earnings growth over the past year (178.5%) exceeded the Medical Equipment industry 15.1%.

Return on Equity

High ROE: GMED's Return on Equity (4.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 23:13
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Globus Medical, Inc. is covered by 26 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Matthew MiksicBarclays
Craig BijouBofA Global Research